Twin Tree Management, LP Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Twin Tree Management, LP

$50 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$233.81 - $287.01 $33.3 Million - $40.8 Million	142,300 New	142,300 $39.1 Million
Q1 2024 May 09, 2024	BUY	$146.51 - $198.2 $424,879 - $574,780	2,900 New	2,900 $433,000
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $670,152 - $879,018	-4,200 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $6.52 Million - $7.98 Million	-38,400 Reduced 90.14%	4,200 $793,000
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $3.55 Million - $4.88 Million	27,600 Added 184.0%	42,600 $7.22 Million
Q2 2020 Aug 12, 2020	SELL	$104.21 - $156.44 $739,891 - $1.11 Million	-7,100 Reduced 32.13%	15,000 $2.22 Million
Q1 2020 May 13, 2020	BUY	$93.12 - $133.99 $1.4 Million - $2.01 Million	15,000 Added 211.27%	22,100 $2.41 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $529,021 - $882,033	7,100 New	7,100 $818,000
Q2 2019 Aug 12, 2019	SELL	$65.86 - $92.79 $1.35 Million - $1.9 Million	-20,500 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$72.76 - $93.45 $1.44 Million - $1.85 Million	19,800 Added 2828.57%	20,500 $1.92 Million
Q4 2018 Feb 13, 2019	SELL	$62.67 - $88.33 $56,403 - $79,497	-900 Reduced 56.25%	700 $51,000
Q3 2018 Nov 09, 2018	BUY	$87.52 - $122.67 $17,504 - $24,534	200 Added 14.29%	1,600 $140,000
Q2 2018 Aug 08, 2018	SELL	$88.31 - $107.8 $4.97 Million - $6.07 Million	-56,300 Reduced 97.57%	1,400 $138,000
Q1 2018 May 09, 2018	SELL	$115.92 - $148.54 $9.09 Million - $11.6 Million	-78,400 Reduced 57.6%	57,700 $6.87 Million
Q4 2017 Feb 09, 2018	BUY	$114.49 - $139.98 $7.13 Million - $8.72 Million	62,300 Added 84.42%	136,100 $17.3 Million
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $5.35 Million - $8.73 Million	73,800	73,800 $8.67 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$3.9 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$2.98 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.25 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.24 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.17 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account